Warp speed development of an anti-Covid-19 vaccine bypasses non-immunological anti-virus defense mechanisms mediated by the alternative cellular energy (ACE) pathway. This pathway was identified in studies on stealthily adapted viruses. These viruses have deletions or mutations in genes coding for relatively few virulence components that are normally targeted by the cellular immune system. Public health officials have denied the existence of these viruses because some were originally derived from viruses that infect monkeys used to make polio vaccines. A new feature of the stealth adaptation process is that genetic sequences from infected cells can be incorporated, in addition to losing some genes. This has allowed the transmission of monkey cellular genes to humans.
Even though the immune system is restricted in its ability to secretly suppress adapted viruses, these viruses, and indeed potentially all viruses, can be suppressed, provided the infected cells have sufficient cellular energy. Therefore, symptomatic COVID-19 infection is a sign that there is insufficient cellular energy in the person’s cells. Conversely, symptomatic infection can be prevented by increasing the cellular energy of those exposed to the virus. Arguably, this can be achieved by repeated inhalation of the mist produced by inhaling nebulizing water with increased levels of a natural energy referred to as KLELEA, an acronym of kinetic energy limiting electrostatic attraction. Name is. A natural source of KELEA active water has been identified in Southern California. It can also be generated using a number of simple processes. The current testing protocol is to inhale gauze with 5 ml of activated water over a period of 5 minutes 5 times a day for two days. The primary outcome is conversion from a positive PCR or antigen test to a negative test two days before the inhalation procedure following the screening procedure. A secondary outcome is self-reported assessments of change in symptom severity. This study is registered at www.clinicaltrials.gov identification number NCT04490824.
Individuals infected with the secretly adapted virus are at a particular risk from receiving the COVID-19 vaccine. First, non-specific immune stimulation from the vaccine may enable an immune response against some residual components on the secretly adapted virus. If these viruses remain in the central nervous system, the resulting inflammation may present as multiple sclerosis or transverse myelitis, as reported using the AstraZeneca vaccine. Second, secretly adapted viruses can incorporate foreign genes and become carriers. Vaccines Covid-19 spikes were pre-existing stealth viruses adapted to contain antigen-coding DNA or RNA sequences that could easily disrupt the body’s angiotensin-mediated regulatory system. It is highly unlikely that these considerations are being addressed by the Food and Drug Administration (FDA) or vaccine manufacturers. In fact, as noted above, the FDA and even the National Institutes of Health (NIH) refuse to acknowledge the existence of monkey-derived stealthily adapted viruses, despite the enormous amount of DNA sequence data on these viruses. has refused.
For a disease that causes symptoms in only a small fraction of infected people, it is completely inappropriate to vaccinate everyone. What is more sensible are means to reduce the susceptibility of people who would otherwise develop symptomatic disease. In addition to direct inhalation of KELEA activated water, there are benefits from the simple wearing of small pouches containing activated water. Activated water can also be used to moisten closed spaces. These methods help to locate naturally active water sources.